Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 803 entries
Sorted by: Best Match Show Resources per page
An improved method for the determination of neutral glycerides in plasma.

The Italian journal of biochemistry

Vanzetti G, Denegri E.
PMID: 5900024
Ital J Biochem. 1964 Nov-Dec;13(6):391-400.

No abstract available.

Cite
Vanzetti G, Denegri E. An improved method for the determination of neutral glycerides in plasma. Ital J Biochem. 1964;13(6):391-400
Vanzetti, G., & Denegri, E. (1964). An improved method for the determination of neutral glycerides in plasma. The Italian journal of biochemistry, 13(6), 391-400.
Vanzetti, G, and Denegri, E. "An improved method for the determination of neutral glycerides in plasma." The Italian journal of biochemistry vol. 13,6 (1964): 391-400.
Vanzetti G, Denegri E. An improved method for the determination of neutral glycerides in plasma. Ital J Biochem. 1964 Nov-Dec;13(6):391-400. PMID: 5900024.
Copy Download .nbib Format: NLM
Extended theory of polarized fluorescence for uniaxial orientation and non-coinciding absorption and emission vectors.

European journal of biochemistry

Rupprecht A.
PMID: 5823106
Eur J Biochem. 1969 Sep;10(2):297-301. doi: 10.1111/j.1432-1033.1969.tb00689.x.
Free Article

No abstract available.

Cite
Rupprecht A. Extended theory of polarized fluorescence for uniaxial orientation and non-coinciding absorption and emission vectors. Eur J Biochem. 1969;10(2):297-301doi: 10.1111/j.1432-1033.1969.tb00689.x.
Rupprecht, A. (1969). Extended theory of polarized fluorescence for uniaxial orientation and non-coinciding absorption and emission vectors. European journal of biochemistry, 10(2), 297-301. https://doi.org/10.1111/j.1432-1033.1969.tb00689.x
Rupprecht, A. "Extended theory of polarized fluorescence for uniaxial orientation and non-coinciding absorption and emission vectors." European journal of biochemistry vol. 10,2 (1969): 297-301. doi: https://doi.org/10.1111/j.1432-1033.1969.tb00689.x
Rupprecht A. Extended theory of polarized fluorescence for uniaxial orientation and non-coinciding absorption and emission vectors. Eur J Biochem. 1969 Sep;10(2):297-301. doi: 10.1111/j.1432-1033.1969.tb00689.x. PMID: 5823106.
Copy Download .nbib Format: NLM
Serum- and glucocorticoid-inducible kinase sgk2 stimulates the transport activity of human organic anion transporters 1 by enhancing the stability of the transporter.

International journal of biochemistry and molecular biology

Xu D, Huang H, Toh MF, You G.
PMID: 27335683
Int J Biochem Mol Biol. 2016 Jun 01;7(1):19-26. eCollection 2016.

Human organic anion transporter 1 (hOAT1) belongs to a family of organic anion transporters that play critical roles in the body disposition of clinically important drugs, including anti-viral therapeutics, anti-cancer drugs, antibiotics, antihypertensives, and anti-inflammatories. hOAT1 is abundantly expressed...

Cite
Xu D, Huang H, Toh MF, et al. Serum- and glucocorticoid-inducible kinase sgk2 stimulates the transport activity of human organic anion transporters 1 by enhancing the stability of the transporter. Int J Biochem Mol Biol. 2016;7(1):19-26
Xu, D., Huang, H., Toh, M. F., & You, G. (2016). Serum- and glucocorticoid-inducible kinase sgk2 stimulates the transport activity of human organic anion transporters 1 by enhancing the stability of the transporter. International journal of biochemistry and molecular biology, 7(1), 19-26.
Xu, Da, et al. "Serum- and glucocorticoid-inducible kinase sgk2 stimulates the transport activity of human organic anion transporters 1 by enhancing the stability of the transporter." International journal of biochemistry and molecular biology vol. 7,1 (2016): 19-26.
Xu D, Huang H, Toh MF, You G. Serum- and glucocorticoid-inducible kinase sgk2 stimulates the transport activity of human organic anion transporters 1 by enhancing the stability of the transporter. Int J Biochem Mol Biol. 2016 Jun 01;7(1):19-26. eCollection 2016. PMID: 27335683; PMCID: PMC4913228.
Copy Download .nbib Format: NLM
Characterization of a starch-hydrolyzing α-amylase produced by Aspergillus niger WLB42 mutated by ethyl methanesulfonate treatment.

International journal of biochemistry and molecular biology

Wang S, Lin C, Liu Y, Shen Z, Jeyaseelan J, Qin W.
PMID: 27335681
Int J Biochem Mol Biol. 2016 Jun 01;7(1):1-10. eCollection 2016.

Aspergillus niger is the most commonly used fungus for commercial amylase production, the increase of amylase activity will be beneficial to the amylase industry. Herein we report a high α-amylase producing (HAP) A. niger WLB42 mutated from A. niger...

Cite
Wang S, Lin C, Liu Y, et al. Characterization of a starch-hydrolyzing α-amylase produced by Aspergillus niger WLB42 mutated by ethyl methanesulfonate treatment. Int J Biochem Mol Biol. 2016;7(1):1-10
Wang, S., Lin, C., Liu, Y., Shen, Z., Jeyaseelan, J., & Qin, W. (2016). Characterization of a starch-hydrolyzing α-amylase produced by Aspergillus niger WLB42 mutated by ethyl methanesulfonate treatment. International journal of biochemistry and molecular biology, 7(1), 1-10.
Wang, Shihui, et al. "Characterization of a starch-hydrolyzing α-amylase produced by Aspergillus niger WLB42 mutated by ethyl methanesulfonate treatment." International journal of biochemistry and molecular biology vol. 7,1 (2016): 1-10.
Wang S, Lin C, Liu Y, Shen Z, Jeyaseelan J, Qin W. Characterization of a starch-hydrolyzing α-amylase produced by Aspergillus niger WLB42 mutated by ethyl methanesulfonate treatment. Int J Biochem Mol Biol. 2016 Jun 01;7(1):1-10. eCollection 2016. PMID: 27335681; PMCID: PMC4913226.
Copy Download .nbib Format: NLM
Nanomedicine: Application of nanoparticles in clinical therapies and diagnostics.

The international journal of biochemistry & cell biology

Kargul J, Irminger-Finger I, Laurent GJ.
PMID: 27130962
Int J Biochem Cell Biol. 2016 Jun;75:140. doi: 10.1016/j.biocel.2016.04.011. Epub 2016 Apr 27.

No abstract available.

Cite
Kargul J, Irminger-Finger I, Laurent GJ. Nanomedicine: Application of nanoparticles in clinical therapies and diagnostics. Int J Biochem Cell Biol. 2016;75:140doi: 10.1016/j.biocel.2016.04.011.
Kargul, J., Irminger-Finger, I., & Laurent, G. J. (2016). Nanomedicine: Application of nanoparticles in clinical therapies and diagnostics. The international journal of biochemistry & cell biology, 75140. https://doi.org/10.1016/j.biocel.2016.04.011
Kargul, Joanna, et al. "Nanomedicine: Application of nanoparticles in clinical therapies and diagnostics." The international journal of biochemistry & cell biology vol. 75 (2016): 140. doi: https://doi.org/10.1016/j.biocel.2016.04.011
Kargul J, Irminger-Finger I, Laurent GJ. Nanomedicine: Application of nanoparticles in clinical therapies and diagnostics. Int J Biochem Cell Biol. 2016 Jun;75:140. doi: 10.1016/j.biocel.2016.04.011. Epub 2016 Apr 27. PMID: 27130962.
Copy Download .nbib Format: NLM
Minimally invasive surgical techniques in the management of differentiated thyroid cancer.

Otorinolaringologia

Tucker N, Mitchem J, Gillanders W.
PMID: 26504264
Otorinolaringologia. 2013 Jun;63(2):53-61.

Thyroid cancer is the fifth most common cancer in women with approximately 60,220 expected new cases in the United States in 2013, and the incidence continues to increase each year. Fortunately, the majority are well-differentiated thyroid cancers with excellent...

Cite
Tucker N, Mitchem J, Gillanders W. Minimally invasive surgical techniques in the management of differentiated thyroid cancer. Otorinolaringologia. 2013;63(2):53-61
Tucker, N., Mitchem, J., & Gillanders, W. (2013). Minimally invasive surgical techniques in the management of differentiated thyroid cancer. Otorinolaringologia, 63(2), 53-61.
Tucker, N, et al. "Minimally invasive surgical techniques in the management of differentiated thyroid cancer." Otorinolaringologia vol. 63,2 (2013): 53-61.
Tucker N, Mitchem J, Gillanders W. Minimally invasive surgical techniques in the management of differentiated thyroid cancer. Otorinolaringologia. 2013 Jun;63(2):53-61. PMID: 26504264; PMCID: PMC4617759.
Copy Download .nbib Format: NLM
Phosphatidylcholine-Mediated Aqueous Diffusion of Cellular Cholesterol Down-Regulates the ABCA1 Transporter in Human Skin Fibroblasts.

International journal of biochemistry research & review

Akopian D, Kawashima RL, Medh JD.
PMID: 26042209
Int J Biochem Res Rev. 2015;5(3):214-224. doi: 10.9734/IJBCRR/2015/14058.

ATP-binding cassette protein A1 (ABCA1) is a cholesterol transporter that contributes to the active transport/removal of excess cellular cholesterol. ABCA1 expression is up-regulated when cells accumulate cholesterol.AIMS: The purpose of this study was to determine any correlation between extracellular...

Cite
Akopian D, Kawashima RL, Medh JD. Phosphatidylcholine-Mediated Aqueous Diffusion of Cellular Cholesterol Down-Regulates the ABCA1 Transporter in Human Skin Fibroblasts. Int J Biochem Res Rev. 2015;5(3):214-224doi: 10.9734/IJBCRR/2015/14058.
Akopian, D., Kawashima, R. L., & Medh, J. D. (2015). Phosphatidylcholine-Mediated Aqueous Diffusion of Cellular Cholesterol Down-Regulates the ABCA1 Transporter in Human Skin Fibroblasts. International journal of biochemistry research & review, 5(3), 214-224. https://doi.org/10.9734/IJBCRR/2015/14058
Akopian, David, et al. "Phosphatidylcholine-Mediated Aqueous Diffusion of Cellular Cholesterol Down-Regulates the ABCA1 Transporter in Human Skin Fibroblasts." International journal of biochemistry research & review vol. 5,3 (2015): 214-224. doi: https://doi.org/10.9734/IJBCRR/2015/14058
Akopian D, Kawashima RL, Medh JD. Phosphatidylcholine-Mediated Aqueous Diffusion of Cellular Cholesterol Down-Regulates the ABCA1 Transporter in Human Skin Fibroblasts. Int J Biochem Res Rev. 2015;5(3):214-224. doi: 10.9734/IJBCRR/2015/14058. PMID: 26042209; PMCID: PMC4450801.
Copy Download .nbib Format: NLM
Interleukin-34 induces monocytic-like differentiation in leukemia cell lines.

International journal of biochemistry and molecular biology

Booker BE, Clark RS, Pellom ST, Adunyah SE.
PMID: 26045972
Int J Biochem Mol Biol. 2015 Mar 20;6(1):1-16. eCollection 2015.

Interleukin-34 (IL-34) is a cytokine consisting of a 39kD homodimer, shown to be a ligand for both the Macrophage Colony Stimulating Factor (M-CSF/CSF-1) receptor and the Receptor-like protein tyrosine phosphatase-zeta (RPTP-ƺ). IL-34 has been shown to promote monocyte viability...

Cite
Booker BE, Clark RS, Pellom ST, et al. Interleukin-34 induces monocytic-like differentiation in leukemia cell lines. Int J Biochem Mol Biol. 2015;6(1):1-16
Booker, B. E., Clark, R. S., Pellom, S. T., & Adunyah, S. E. (2015). Interleukin-34 induces monocytic-like differentiation in leukemia cell lines. International journal of biochemistry and molecular biology, 6(1), 1-16.
Booker, Burthia E, et al. "Interleukin-34 induces monocytic-like differentiation in leukemia cell lines." International journal of biochemistry and molecular biology vol. 6,1 (2015): 1-16.
Booker BE, Clark RS, Pellom ST, Adunyah SE. Interleukin-34 induces monocytic-like differentiation in leukemia cell lines. Int J Biochem Mol Biol. 2015 Mar 20;6(1):1-16. eCollection 2015. PMID: 26045972; PMCID: PMC4443290.
Copy Download .nbib Format: NLM
Modulation of formation of the 3'-end of the human argininosuccinate synthetase mRNA by GT-repeat polymorphism.

International journal of biochemistry and molecular biology

Tseng SH, Cheng CY, Huang MZ, Chung MY, Su TS.
PMID: 24380022
Int J Biochem Mol Biol. 2013 Dec 15;4(4):179-90. eCollection 2013.

Microsatellites are abundant in the human genome and may acquire context-dependent functions. A highly polymorphic GT microsatellite is located downstream of the poly(A) signal of the human argininosuccinate synthetase (ASS1) gene. The ASS1 participates in urea and nitric oxide...

Cite
Tseng SH, Cheng CY, Huang MZ, et al. Modulation of formation of the 3'-end of the human argininosuccinate synthetase mRNA by GT-repeat polymorphism. Int J Biochem Mol Biol. 2013;4(4):179-90
Tseng, S. H., Cheng, C. Y., Huang, M. Z., Chung, M. Y., & Su, T. S. (2013). Modulation of formation of the 3'-end of the human argininosuccinate synthetase mRNA by GT-repeat polymorphism. International journal of biochemistry and molecular biology, 4(4), 179-90.
Tseng, Shih-Heng, et al. "Modulation of formation of the 3'-end of the human argininosuccinate synthetase mRNA by GT-repeat polymorphism." International journal of biochemistry and molecular biology vol. 4,4 (2013): 179-90.
Tseng SH, Cheng CY, Huang MZ, Chung MY, Su TS. Modulation of formation of the 3'-end of the human argininosuccinate synthetase mRNA by GT-repeat polymorphism. Int J Biochem Mol Biol. 2013 Dec 15;4(4):179-90. eCollection 2013. PMID: 24380022; PMCID: PMC3867704.
Copy Download .nbib Format: NLM
Effects of Melatonin-Aided Therapy on the Glutathione Antioxidant System Activity and Liver Protection.

Journal of biochemical and molecular toxicology

Popov SS, Shulgin KK, Popova TN, Pashkov AN, Agarkov AA, de Carvalho MAAP.
PMID: 25903262
J Biochem Mol Toxicol. 2015 Oct;29(10):449-457. doi: 10.1002/jbt.21705. Epub 2015 Apr 22.

Acute hepatitis results from oxidative stress triggered by hepatotoxic drugs causing liver injury and the activation of caspases cascade. The glutathione antioxidant system protects against reactive oxygen species and mitigates development of these processes. The effectiveness of silymarin, a...

Cite
Popov SS, Shulgin KK, Popova TN, et al. Effects of Melatonin-Aided Therapy on the Glutathione Antioxidant System Activity and Liver Protection. J Biochem Mol Toxicol. 2015;29(10):449-457doi: 10.1002/jbt.21705.
Popov, S. S., Shulgin, K. K., Popova, T. N., Pashkov, A. N., Agarkov, A. A., & de Carvalho, M. A. A. P. (2015). Effects of Melatonin-Aided Therapy on the Glutathione Antioxidant System Activity and Liver Protection. Journal of biochemical and molecular toxicology, 29(10), 449-457. https://doi.org/10.1002/jbt.21705
Popov, Serguey S, et al. "Effects of Melatonin-Aided Therapy on the Glutathione Antioxidant System Activity and Liver Protection." Journal of biochemical and molecular toxicology vol. 29,10 (2015): 449-457. doi: https://doi.org/10.1002/jbt.21705
Popov SS, Shulgin KK, Popova TN, Pashkov AN, Agarkov AA, de Carvalho MAAP. Effects of Melatonin-Aided Therapy on the Glutathione Antioxidant System Activity and Liver Protection. J Biochem Mol Toxicol. 2015 Oct;29(10):449-457. doi: 10.1002/jbt.21705. Epub 2015 Apr 22. PMID: 25903262.
Copy Download .nbib Format: NLM
Identification of an NADP/thioredoxin system in Chlamydomonas reinhardtii.

Planta

Huppe HC, Picaud A, Buchanan BB, Miginiac-Maslow M.
PMID: 24186583
Planta. 1991 Dec;186(1):115-21. doi: 10.1007/BF00201506.

The protein components of the NADP/thioredoxin system, NADP-thioredoxin reductase (NTR) and thioredoxin h, have been purified and characterized from the green alga, Chlamydomonas reinhardtii. The analysis of this system confirms that photoautotrophic Chlamydomonas cells resemble leaves in having both...

Cite
Huppe HC, Picaud A, Buchanan BB, et al. Identification of an NADP/thioredoxin system in Chlamydomonas reinhardtii. Planta. 1991;186(1):115-21doi: 10.1007/BF00201506.
Huppe, H. C., Picaud, A., Buchanan, B. B., & Miginiac-Maslow, M. (1991). Identification of an NADP/thioredoxin system in Chlamydomonas reinhardtii. Planta, 186(1), 115-21. https://doi.org/10.1007/BF00201506
Huppe, H C, et al. "Identification of an NADP/thioredoxin system in Chlamydomonas reinhardtii." Planta vol. 186,1 (1991): 115-21. doi: https://doi.org/10.1007/BF00201506
Huppe HC, Picaud A, Buchanan BB, Miginiac-Maslow M. Identification of an NADP/thioredoxin system in Chlamydomonas reinhardtii. Planta. 1991 Dec;186(1):115-21. doi: 10.1007/BF00201506. PMID: 24186583.
Copy Download .nbib Format: NLM
Model of the Second Most Abundant Cisplatin-DNA Cross-Link: X-ray Crystal Structure and Conformational Analysis of cis-[(NH(3))(2)Pt(9-MeA-N7)(9-EtGH-N7)](NO(3)).2H(2)O (9-MeA = 9-Methyladenine; 9-EtGH = 9-Ethylguanine).

Inorganic chemistry

Schröder G, Kozelka J, Sabat M, Fouchet MH, Beyerle-Pfnür R, Lippert B.
PMID: 11666386
Inorg Chem. 1996 Mar 13;35(6):1647-1652. doi: 10.1021/ic950754s.

A model compound of the second most abundant DNA adduct of the antitumor agent cisplatin has been synthesized and structurally and spectroscopically characterized and its conformational behavior examined: cis-[(NH(3))(2)Pt(9-MeA-N7)(9-EtGH-N7)](NO(3))(2).2H(2)O (9-MeA = 9-methyladenine; 9-EtGH = 9-ethylguanine) crystallizes in the monoclinic...

Cite
Schröder G, Kozelka J, Sabat M, et al. Model of the Second Most Abundant Cisplatin-DNA Cross-Link: X-ray Crystal Structure and Conformational Analysis of cis-[(NH(3))(2)Pt(9-MeA-N7)(9-EtGH-N7)](NO(3)).2H(2)O (9-MeA = 9-Methyladenine; 9-EtGH = 9-Ethylguanine). Inorg Chem. 1996;35(6):1647-1652doi: 10.1021/ic950754s.
Schröder, G., Kozelka, J., Sabat, M., Fouchet, M. H., Beyerle-Pfnür, R., & Lippert, B. (1996). Model of the Second Most Abundant Cisplatin-DNA Cross-Link: X-ray Crystal Structure and Conformational Analysis of cis-[(NH(3))(2)Pt(9-MeA-N7)(9-EtGH-N7)](NO(3)).2H(2)O (9-MeA = 9-Methyladenine; 9-EtGH = 9-Ethylguanine). Inorganic chemistry, 35(6), 1647-1652. https://doi.org/10.1021/ic950754s
Schröder, Guy, et al. "Model of the Second Most Abundant Cisplatin-DNA Cross-Link: X-ray Crystal Structure and Conformational Analysis of cis-[(NH(3))(2)Pt(9-MeA-N7)(9-EtGH-N7)](NO(3)).2H(2)O (9-MeA = 9-Methyladenine; 9-EtGH = 9-Ethylguanine)." Inorganic chemistry vol. 35,6 (1996): 1647-1652. doi: https://doi.org/10.1021/ic950754s
Schröder G, Kozelka J, Sabat M, Fouchet MH, Beyerle-Pfnür R, Lippert B. Model of the Second Most Abundant Cisplatin-DNA Cross-Link: X-ray Crystal Structure and Conformational Analysis of cis-[(NH(3))(2)Pt(9-MeA-N7)(9-EtGH-N7)](NO(3)).2H(2)O (9-MeA = 9-Methyladenine; 9-EtGH = 9-Ethylguanine). Inorg Chem. 1996 Mar 13;35(6):1647-1652. doi: 10.1021/ic950754s. PMID: 11666386.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 803 entries